| abstract |
Placental stem cells isolated for use in a method for suppressing the proliferation of cells of a bone-related cancer in a human individual, wherein the method consists of contacting said cells of a bone-related cancer, with a plurality of placental stem cells, for a time sufficient for said placental stem cells to suppress the proliferation of said bone-related cancer cells, as compared to a plurality of said bone-related cancer cells that have not been contacted with placental stem cells, wherein said bone-related cancer cells are chondrosarcoma cells, bone cancer cells, neuroblastoma cells, osteosarcoma cells, Ewing sarcoma cells, chordoma cells, cells of a malignant fibrous histiocytoma of bone, or cells of a bone fibrosarcoma, where said placenta stem cells Rias are adherent to tissue culture plastic, are CD34-, CD10 +, CD105 + and CD200 +, as can be detected by flow cytometry, and are not trophoblasts, cytotrophoblasts or mesenchymal stem cells derived from bone marrow. |